Denison Pharmaceuticals

G & G Technologies Inc, based in Coventry, RI, specializes in providing a wide range of innovative products and solutions for biotech manufacturing processes. From single-use systems to custom components and services like design and engineering, the company offers comprehensive support to help businesses achieve high-yield production. Their offerings include skids, filtration systems, mixing equipment, and more, all designed to meet the needs of classified spaces and ensure efficient and compliant operations. With a focus on quality and customization, G & G Technologies is a trusted partner for companies looking to enhance their biotech manufacturing capabilities.Generated from the website

Novobiotic Pharmaceuticals is a biotechnology company located in Cambridge, Massachusetts, specializing in the development of innovative pharmaceutical solutions. The company focuses on harnessing the potential of natural products, particularly from microbial sources, to address unmet medical needs. With a dedicated team of scientists and researchers, Novobiotic Pharmaceuticals is committed to advancing the field of drug discovery and development. Their work emphasizes the importance of scientific research in creating effective therapies for various health challenges. Generated from the website

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website